VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 41 filers reported holding VERRICA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14 | -41.7% | 3,632 | -12.9% | 0.00% | – |
| Q2 2023 | $24 | -78.2% | 4,172 | -75.3% | 0.00% | – |
| Q1 2023 | $110 | -99.4% | 16,922 | +696.3% | 0.00% | – |
| Q1 2022 | $17,000 | -94.2% | 2,125 | -93.3% | 0.00% | – |
| Q4 2021 | $292,000 | +335.8% | 31,792 | +494.0% | 0.00% | – |
| Q3 2021 | $67,000 | +235.0% | 5,352 | +213.5% | 0.00% | – |
| Q2 2021 | $20,000 | -87.3% | 1,707 | -83.6% | 0.00% | – |
| Q1 2021 | $157,000 | +241.3% | 10,399 | +159.0% | 0.00% | – |
| Q4 2020 | $46,000 | +4.5% | 4,015 | -30.4% | 0.00% | – |
| Q3 2020 | $44,000 | -42.1% | 5,767 | -16.4% | 0.00% | – |
| Q2 2020 | $76,000 | +65.2% | 6,902 | +61.5% | 0.00% | – |
| Q1 2020 | $46,000 | -77.6% | 4,274 | -66.9% | 0.00% | – |
| Q4 2019 | $205,000 | +118.1% | 12,895 | +102.9% | 0.00% | – |
| Q3 2019 | $94,000 | -3.1% | 6,356 | -23.5% | 0.00% | – |
| Q2 2019 | $97,000 | +94.0% | 8,309 | +81.9% | 0.00% | – |
| Q1 2019 | $50,000 | +42.9% | 4,568 | +110.2% | 0.00% | – |
| Q3 2018 | $35,000 | – | 2,173 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Altium Capital Management LP | 256,244 | $3,203,000 | 0.84% |
| Perceptive Advisors | 3,610,412 | $45,130,000 | 0.66% |
| Orbimed Advisors | 1,479,733 | $18,497,000 | 0.20% |
| Fosun International Ltd | 282,408 | $3,530,000 | 0.18% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 728,236 | $9,103,000 | 0.14% |
| SteelPeak Wealth, LLC | 133,161 | $1,665,000 | 0.11% |
| HighVista Strategies LLC | 10,944 | $137,000 | 0.09% |
| Capital Investment Advisory Services, LLC | 15,125 | $189,000 | 0.02% |
| MML INVESTORS SERVICES, LLC | 44,875 | $561,000 | 0.00% |
| BECK MACK & OLIVER LLC | 10,000 | $125,000 | 0.00% |